Home  /  Health & Fitness Apps  / Cancer-killing drug
Cancer-killing drug Application icon

Cancer-killing drug 1.0

5.3 MB / 1+ Downloads / Rating 5.0 - 1 reviews


See previous versions

Cancer-killing drug, developed and published by Dinatale, has released its latest version, 1.0, on 2018-08-27. This app falls under the Health & Fitness category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

Cancer-killing drug APK available on this page is compatible with all Android devices that meet the required specifications (Android 4.1+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.andromo.dev712859.app847451

Updated: 7 years ago

Developer Name: Dinatale

Category: Health & Fitness

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing Cancer-killing drug on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Reviews

1 ★, on 2020-05-14
Ok

Previous Versions

Cancer-killing drug 1.0
2018-08-27 / 5.3 MB / Android 4.1+

About this app

Properly mixed, the medicine came out as a dark brown liquid. A nurse brought the intravenous bag to the side of a recliner, where a man with brain cancer sat. The nurse hung the plump bag on a stand and prepared the treatment for delivery. The moment had arrived for BXQ-350 to meet its first human patient.

For the man, and for the medicine, the stakes could not have been higher.

BXQ-350, by Bexion Pharmaceuticals of Covington, Kentucky, is a first-of-its-kind cancer treatment, a new approach discovered, developed and tested in Greater Cincinnati. The innovative drug is made from a human protein and does something unlike any other: It weaponizes the special mechanics of cancer to destroy it, without affecting healthy cells.

That the treatment killed nothing but cancer so jarred federal regulators that they had demanded more research in animals. But on a September day in 2016 at the University of Cincinnati’s Barrett Cancer Center, brainpower and money at last brought BXQ-350 to a critical first test for government approval.

In the infusion center, the nurse asked Bob Rulli of Fort Thomas if he was ready. She aimed the needle and punctured his arm. Patient No. 1 watched his body take in the dark brown mystery.

App Permissions

Allows applications to open network sockets.
Allows applications to access information about networks.
Allows applications to access information about Wi-Fi networks.